Kilitch Drugs (India) Ltd
KILI

Kilitch Drugs (India) Ltd (KILITCH)

₹160.11.04%

Key Stats

₹159.45
Day's Price Range
₹162.8
₹145
52-Week Price Range
₹275.1
1 Month Return-3.21 %
3 Month Return-4.24 %
1 Year Return-25.33 %

Company Financials

  • Quarterly
  • Annual
Value in ₹ crore

Peer Comparsion

PE
Rank 186
33.49
EPS
Rank 192
₹4.72
BVPS
Rank 146
₹82.05
Dividend Yield
Rank 179
ROE
Rank 367
3.32%
Price To Book Ratio
Rank 94
1.93
Debt To Asset
Rank 205
0.37

Company Information

Incorporated in May 92 as a public limited company Kilitch Drugs India KDIL went public in Feb.94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets capsulesliquid orals ointments creams and injectables. Even before the plant was commissioned the company came out with a rights issue in Oct.95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions O T C and ethical.A Pharmaceutical formulation plant at Sanaa Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with AlFath Trading Corporation.It also entered into an agreement with a Miami company for the export of their medicine to West Indies south and central America.The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5cr tanning unit which was implemented in the year 199596. The company had set up a bulk drug unit at Patalganga Maharashtra for producing raw materials for formulations. The company exports to Sudan Yemen middleeast Miami and certain south American companies. KDIL started marketing a range of injectables from the factory on ethical basis. The company also introduced a new product clueplus BonBon Gripe Water and Kilitch Balm.
OrganisationKilitch Drugs (India) Ltd
HeadquartersThane
IndustryPharmaceuticals